Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 2 |
2015 | 1 |
2016 | 1 |
2017 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Discovery of Cycloalkyl[c]thiophenes as Novel Scaffolds for Hypoxia-Inducible Factor-2α Inhibitors.
J Med Chem. 2023 Jul 13;66(13):8666-8686. doi: 10.1021/acs.jmedchem.3c00332. Epub 2023 Jul 5.
J Med Chem. 2023.
PMID: 37403966
Differences in Sustained Cellular Effects of MET inhibitors Are Driven by Prolonged Target Engagement and Lysosomal Retention.
Berges N, Klug JH, Eicher A, Loehr J, Schwarz D, Bomke J, Leuthner B, Perrin D, Schadt O.
Berges N, et al.
Mol Pharmacol. 2023 Feb;103(2):77-88. doi: 10.1124/molpharm.122.000590. Epub 2022 Nov 18.
Mol Pharmacol. 2023.
PMID: 36400432
Item in Clipboard
A Microfluidic 3D Endothelium-on-a-Chip Model to Study Transendothelial Migration of T Cells in Health and Disease.
de Haan L, Suijker J, van Roey R, Berges N, Petrova E, Queiroz K, Strijker W, Olivier T, Poeschke O, Garg S, van den Broek LJ.
de Haan L, et al. Among authors: berges n.
Int J Mol Sci. 2021 Jul 30;22(15):8234. doi: 10.3390/ijms22158234.
Int J Mol Sci. 2021.
PMID: 34361000
Free PMC article.
Item in Clipboard
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion protein.
Hristodorov D, Amoury M, Mladenov R, Niesen J, Arens K, Berges N, Hein L, Di Fiore S, Pham AT, Huhn M, Helfrich W, Fischer R, Thepen T, Barth S.
Hristodorov D, et al. Among authors: berges n.
Mol Cancer Ther. 2014 Sep;13(9):2194-202. doi: 10.1158/1535-7163.MCT-13-0781. Epub 2014 Jun 30.
Mol Cancer Ther. 2014.
PMID: 24980949
Item in Clipboard
In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.
Niesen J, Brehm H, Stein C, Berges N, Pardo A, Fischer R, Ten Haaf A, Gattenlöhner S, Tur MK, Barth S.
Niesen J, et al. Among authors: berges n.
J Cancer Res Clin Oncol. 2015 Jun;141(6):1049-61. doi: 10.1007/s00432-014-1884-z. Epub 2014 Nov 30.
J Cancer Res Clin Oncol. 2015.
PMID: 25433506
Item in Clipboard
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
Amoury M, Bauerschlag D, Zeppernick F, von Felbert V, Berges N, Di Fiore S, Mintert I, Bleilevens A, Maass N, Bräutigam K, Meinhold-Heerlein I, Stickeler E, Barth S, Fischer R, Hussain AF.
Amoury M, et al. Among authors: berges n.
Oncotarget. 2016 Aug 23;7(34):54925-54936. doi: 10.18632/oncotarget.10705.
Oncotarget. 2016.
PMID: 27448975
Free PMC article.
Item in Clipboard
Toward Discovery of Novel Microtubule Targeting Agents: A SNAP-tag-Based High-Content Screening Assay for the Analysis of Microtubule Dynamics and Cell Cycle Progression.
Berges N, Arens K, Kreusch V, Fischer R, Di Fiore S.
Berges N, et al.
SLAS Discov. 2017 Apr;22(4):387-398. doi: 10.1177/2472555216685518. Epub 2017 Jan 10.
SLAS Discov. 2017.
PMID: 28328318
Free article.
Item in Clipboard
Cite
Cite